Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

The publisher, the industry analysis specialist, has released its latest report “Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.

Denmark's pharmaceutical and biotechnology industries are among the largest and most advanced in the world as they offer attractive economic prospects to various local and multinational companies, including cooperative R&D initiatives, locations for European headquarters, and strategic partnerships. The availability of a highly automated and sophisticated pharmaceutical and biotech production landscape, a friendly corporate climate, and a top-notch research environment, among others, promote the expansion of pharmaceutical manufacturing facilities in Denmark. In terms of US dollars, Denmark's pharmaceutical market increased from $3.3 billion in 2015 to $3.9 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 3.5%. It was forecast to increase to $4.0 billion in 2021. In terms of Danish Krone (DKK), Denmark's pharmaceutical market increased from DKK21.9 billion in 2015 to DKK25.3 billion in 2020, at a CAGR of 2.9%. It was forecast to increase to DKK26 billion in 2021. Denmark is one of Europe's top countries for medical technology. It offers attractive collaborations in R&D, design and innovation expertise, test and demonstration facilities, public-private partnerships, and high-tech manufacturing. In 2016, the medical devices market in Denmark was worth $1.4 billion, which increased at a CAGR of 6.3% to $1.9 billion in 2021. In 2021, the Danish government revealed its new life sciences industrial strategy, comprising 38 new projects across seven major industries. The strategy emphasized improving the environment for R&D and using health data, as well as securing a highly educated workforce and laying the framework for the country's industry's worldwide expansion, which aimed to benefit Denmark's patients and economy.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, GlaxoSmithKline (GSK), Sanofi, Novo Nordisk, and Leo
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Zimmer Biomet, Getinge, and Coloplast
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country's healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges to growth in the Danish healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights: Facts About the Danish Healthcare Market
2.3 Key Highlights: Healthcare Startups in Denmark
2.4 Key Events: Danish Healthcare Industry, 2016-22
2.5 Key Events: Denmark Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021-22
2.7 Key Events: Top Completed Deals by Value, 2022
2.8 Country Profile, Denmark, 2022

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Denmark
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Market Segments, Generics, Denmark
3.7 Pharmaceutical Market - Market Segments, Biologics and Biosimilars, Denmark
3.8 Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Denmark
3.9 Major Therapeutic Areas, Denmark
3.10 COVID-19 Epidemiology, Denmark
3.11 COVID-19 Impact and Developments, Denmark
3.12 COVID-19 Impact and Developments in the Healthcare Market, Denmark
3.13 COVID-19 Clinical Trials Landscape, Denmark
3.14 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Denmark, 2020-22
6.2 Deal Analysis: Medical Device Market, Denmark, 2020-22

7. HealthTech Landscape

7.1 HealthTech Landscape, Denmark
7.2 HealthTech Deals Landscape, Denmark
7.3 Key Healthtech Deals, Denmark
7.4 Adoption of Technology in Healthcare, Denmark
7.5 Digital Statistics, Denmark
7.6 Digital Health Regulations, Denmark
7.7 Healthtech Landscape: Benefits and Risks, Denmark

8. Market Access

8.1 Overview of Healthcare System, Denmark
8.2 Reimbursement Process, Denmark
8.3 Overview of Insurance Providers, Denmark
8.4 Healthcare Spending and Pharmaceutical Price Index, Denmark
8.5 Pricing Policies, Denmark
8.6 Regulatory Landscape, Denmark
8.6.1 Marketing Authorization for Pharmaceutical Products, Denmark
8.6.2 Marketing Authorization for Pharmaceutical Products, EU
8.6.3 Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Denmark
8.6.4 Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Denmark
8.6.5 Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Denmark
8.6.6 Marketing Authorization for Pharmaceutical Products, National Procedure, Denmark
8.6.7 Marketing Authorization for Pharmaceutical Products, Generic Medicines, Denmark
8.6.8 Marketing Authorization for Pharmaceutical Products, Biosimilars, Denmark
8.6.9 Marketing Authorization for Medical Devices, Denmark
8.6.10 Intellectual Property Rights, Patents, Denmark
8.6.11 Intellectual Property Rights, Trademarks, Denmark
8.6.12 Clinical Trial Regulation Process, Denmark
8.6.13 Pharmaceutical Clinical Trials Landscape, Denmark
8.6.14 Medical Devices Clinical Trials Landscape, Denmark
8.6.15 Exports and Imports Regulations, Denmark
8.6.16 Pharmacy License Regulations, Denmark
8.6.17 Online Pharmacy Regulations, Denmark
8.6.18 Pharmaceutical Advertising Regulations, Denmark
8.6.19 Labeling and Packaging Regulations, Denmark

9. Country Healthcare Landscape

9.1 Denmark Healthcare Policy Highlights
9.2 Healthcare Facilities, Denmark
9.3 Life Expectancy and Immunization Rate, Denmark
9.4 Environmental Health, Denmark
9.5 Healthcare Personnel, Denmark
9.6 Disease Burden, Denmark
9.7 Healthcare Expenditure, Denmark
9.8 Healthcare Spending Components and Pharmaceutical Spending, Denmark

10 Trade Associations, Denmark11 Trade Fairs, Denmark12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables

Table 1: Patent expiry of drugs, EU, 2022
Table 2: COVID-19 indicators (number), Denmark and Global, 2022
Table 3: COVID-19-related travel restrictions, Denmark, 2020-22
Table 4: Medical devices market, major segments ($M), Denmark, 2021
Table 5: Hospital supplies market, revenue ($M) and market share (%) of major companies, Denmark, 2021
Table 6: Wound care management market, revenue ($M) and market share (%) of major companies, Denmark, 2021
Table 7: Cardiovascular devices market, revenue ($M) and market share (%) of major companies, Denmark, 2021
Table 8: Orthopedic devices market, revenue ($M) and market share (%) of major companies, Denmark, 2021
Table 9: General surgery devices market, revenue ($M) and market share (%) of major companies, Denmark, 2021
Table 10: Net assessment and clock stop times, Denmark, 2022
Table 11: Market authorization fees, Denmark, 2022
Table 12: Registration fees for medical devices manufacturers, Denmark, 2022
Table 13: Patent fees, Denmark, 2022
Table 14: Trademark fees, Denmark, 2022
Table 15: Clinical trial fees, Denmark, 2022
Table 16: Trade fairs, Denmark, 2022

List of Figures

Figure 1: Pharmaceutical market, revenue (DKKB and $B), Denmark, 2015-21
Figure 2: Medical devices market, revenue ($B), Denmark, 2016-22
Figure 3: Healthcare start-ups in Denmark, 2022
Figure 4: Country profile, Denmark, 2022
Figure 5: Pharmaceutical market, revenue (DKKB and $B), Denmark, 2015-21
Figure 6: Pharmaceutical market, revenue forecast (DKKB and $B), Denmark, 2022-27
Figure 7: Danish growth strategy for life sciences, Denmark, 2018-23
Figure 8: Pharmaceutical exports ($B), Denmark, 2015-21
Figure 9: Top export partners, Denmark, 2021
Figure 10: Pharmaceutical imports ($B), Denmark, 2015-21
Figure 11: Top import partners, Denmark, 2021
Figure 12: Pharmaceutical supply channel, Denmark, 2022
Figure 13: Total sales of generic medicines in the primary health sector (DKKM and $M), Denmark, 2016-22
Figure 14: Generic drugs usage, third-party-payer market, (% share by value and volume), Denmark, 2016-22
Figure 15: Generic drugs usage, community pharmacy market, (% share by value and volume), Denmark, 2016-22
Figure 16: OTC medicines market, revenue ($M), Denmark, 2015-21
Figure 17: OTC market by sub-categories of drugs, revenue ($M), Denmark, 2021
Figure 18: Major therapeutic areas by pharmaceutical sales ($M), Denmark, 2021
Figure 19: Major therapeutic areas by DDD per 1000 inhabitants per day, Denmark, 2021
Figure 20: COVID-19 (number of cases), Denmark, 2020-22
Figure 21: COVID-19 (number of deaths), Denmark, 2020-22
Figure 22: Stringency index, COVID-19, Denmark, 2020-22
Figure 23: Containment and health index, COVID-19, Denmark, 2020-22
Figure 24: Top five COVID-19 markets by product categories (number of available marketed products), Denmark, 2020-22
Figure 25: Top five COVID-19 markets by equipment type (number of available marketed products), Denmark, 2020-22
Figure 26: Top five COVID-19 device classes (number of available marketed products), Denmark, 2020-22
Figure 27: Top five COVID-19 product manufacturers (number of available marketed products), Denmark, 2020-22
Figure 28: COVID-19 Vaccine doses administration, number of vaccine doses administered, Denmark, 2020-22
Figure 29: COVID-19 Vaccine booster doses administration, number of booster doses administered per 100 population, Denmark, 2021-22
Figure 30: COVID-19 clinical trial sponsors by trial count, Denmark, 2020-22
Figure 31: COVID-19 clinical trials count by phase, Denmark, 2020-22
Figure 32: COVID-19 clinical trials count by trial status, Denmark, 2020-22
Figure 33: Medical devices market, ($B), Denmark, 2016-21
Figure 34: Medical devices market, revenue forecast ($B), Denmark 2022-27
Figure 35: Medical devices market, major segments (%), Denmark, 2021
Figure 36: Hospital supplies market, revenue ($M), Denmark, 2017-27
Figure 37: Hospital supplies market, market share of major players (%), Denmark, 2021
Figure 38: Wound care management market, revenue ($M), Denmark, 2017-27
Figure 39: Wound care management market, market share of major players (%), Denmark, 2021
Figure 40: Cardiovascular devices market, revenue ($M), Denmark, 2017-27
Figure 41: Cardiovascular devices market, market share of major players (%), Denmark, 2021
Figure 42: Orthopedic devices market, revenue ($M), Denmark, 2017-27
Figure 43: Orthopedic devices market, market share of major players (%), Denmark, 2021
Figure 44: General surgery devices market, revenue ($M), Denmark, 2017-27
Figure 45: General surgery devices market, market share of major players (%), Denmark, 2021
Figure 46: Diagnostics market, revenue ($M), Denmark, 2016-21
Figure 47: Diagnostics market, revenue forecast ($M), Denmark, 2022-27
Figure 48: Medical devices market, revenue ($B) of major companies, Denmark, 2021
Figure 49: Deal value and deal count, pharmaceutical market, Denmark, 2020-22
Figure 50: Deal value and deal count subtypes, pharmaceutical market, Denmark, 2020-22
Figure 51: Deal value and deal count, quarterly, pharmaceutical market, Denmark, 2020-22
Figure 52: Top therapy areas by deal value ($M), pharmaceutical market, Denmark, 2020-22
Figure 53: VC deals quarterly, (by value and by number), pharmaceutical market, Denmark, 2020-22
Figure 54: Top therapy areas by deal count, pharmaceutical market, Denmark, 2020-22
Figure 55: M&A deals quarterly, (by value and by number), pharmaceutical market, Denmark, 2020-22
Figure 56: Deal value and deal count, medical devices market, Denmark, 2020-22
Figure 57: Deal value and deal count subtypes, medical devices market, Denmark, 2020-22
Figure 58: Deal value and deal count, quarterly, medical devices market, Denmark, 2020-22
Figure 59: Top equipment sectors by deal value ($M), medical devices market, Denmark, 2020-22
Figure 60: M&A deals, quarterly (by value and by number), medical devices market, Denmark, 2020-22
Figure 61: Top equipment sectors by deal count, medical devices market, Denmark, 2020-22
Figure 62: VC deals quarterly, (by value and by number), medical devices market, Denmark, 2020-22
Figure 63: Focus areas of Digital Health Strategy 2018-22, Denmark
Figure 64: Deal value ($M) and deal count (number of deals), Healthtech, Denmark, 2020-22
Figure 65: Deal value ($M) and deal count (number of deals) by deal sub-category, Healthtech, Denmark, 2020-22
Figure 66: Examples of digital health solutions by Danish Health Data Authority, Denmark, 2022
Figure 67: Digital health legislation principles, Denmark, 2018
Figure 68: Overview of Healthcare System, Denmark, 2022
Figure 69: Drug reimbursement (medicines reimbursement board process), Denmark, 2022
Figure 70: Private health insurance (% of total population), Denmark, 2012-22
Figure 71: Pharmaceutical Price Index, Denmark, 2012-22
Figure 72: OOP expenditure (% of total expenditure on health), Denmark, 2012-21
Figure 73: Danish Medicines Agency, Organization Chart, 2022
Figure 74: Drug authorization procedures, EU, 2022
Figure 75: The centralized procedure, Denmark, 2022
Figure 76: The decentralized procedure, Denmark, 2022
Figure 77: Mutual recognition procedure, Denmark, 2022
Figure 78: New drug approval process, Denmark, 2022
Figure 79: Medical device classification system, EU, 2022
Figure 80: Conformity assessment of Class I medical devices, EU,2022
Figure 81: Conformity assessment of Class IIa medical devices, EU,2022
Figure 82: Conformity assessment of Class IIb medical devices, EU,2022
Figure 83: Conformity assessment of Class III medical devices, EU,2022
Figure 84: Clinical trial approval process, Denmark, 2022
Figure 85: Pharmaceutical clinical trials count by trial status, Denmark, 2021-22
Figure 86: Top five pharmaceutical clinical trials sponsors by count, Denmark, 2021-22
Figure 87: Pharmaceutical clinical trials count by phase, Denmark, 2021-22
Figure 88: Pharmaceutical clinical trials count by therapy area, Denmark, 2021-22
Figure 89: Medical device clinical trials count by trial status, Denmark, 2021-22
Figure 90: Medical device clinical trials count by therapy area, Denmark, 2021-22
Figure 91: Medical device clinical trials count by market categories, Denmark, 2021-22
Figure 92: Top five medical device clinical trials sponsors by count, Denmark, 2021-22
Figure 93: Green EU logo, 2022
Figure 94: Number of public hospital beds (per 1,000 population), Denmark, 2015-22
Figure 95: Number of private hospital beds (per 1,000 population), Denmark, 2015-22
Figure 96: Number of hospital beds by function (per 1,000 population), Denmark, 2015-22
Figure 97: Number of CT scanners and PET scanners (per million population), Denmark, 2015-22
Figure 98: Immunization rate (%), Denmark, 2015-22
Figure 99: Life expectancy of males and females at birth (years), Denmark, 2015-22
Figure 100: CO2 emissions (million tons), Denmark, 2015-22
Figure 101: PM2.5 (µg per m3), Denmark, 2015-22
Figure 102: Practicing physicians (per 1,000 population), Denmark, 2015-22
Figure 103: Practicing dentists (per 1,000 population), Denmark, 2015-22
Figure 104: Practicing pharmacists (per 1,000 population), Denmark, 2015-22
Figure 105: Practicing nurses (per 1,000 population), Denmark, 2015-22
Figure 106: Major causes of mortality (per 100,000 population), Denmark, 2019
Figure 107: Major causes of male mortality (per 100,000 population), Denmark, 2019
Figure 108: Major causes of female mortality (per 100,000 population), Denmark, 2019
Figure 109: DALYs by major disease (per 100,000 population), Denmark, 2019
Figure 110: Healthcare expenditure as a percentage of GDP (%), Denmark, 2015-22
Figure 111: Health expenditure share (% of total health spending), Denmark, 2015-22
Figure 112: Pharmaceutical spending (% of health spending and $ per capita), Denmark, 2015-22
Figure 113: Healthcare expenditure components by function (% of total health expenditure), Denmark, 2021

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1927EUR$1,995USD£1,599GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2890EUR$2,992USD£2,398GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3854EUR$3,990USD£3,198GBP

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes:

Reasons to Buy

Table of Contents

Related Topics

Related Reports

Regulatory Affairs Market by Technology Type, Industry Verticals, Application Areas, Consumer Demographics, Product Types, Business Models - Global Forecast 2025-2030

Medical Device Cleaning Market by Process, Device Type, Method of Deployment, Type, Material Compatibility, Application, End-User - Global Forecast 2025-2030

Refurbished Medical Imaging Devices Market Size, Share & Trends Analysis Report by Modality (CT, Nuclear Imaging), End-use (Diagnostic Imaging Centers, Hospitals), Region, and Segment Forecasts, 2024-2030

Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), Service, Device Type, Region, and Segment Forecasts, 2024-2030

Radiofrequency Ablation Devices Market 2024-2028